Chronic disease in the elderly: A vital rationale for the revival of internal medicine

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 4, 2009, Pages 248-254

  Panaszek, Bernard ^a   Machaj, Zbigniew ^a   Bogacka, Ewa ^a   Lindner, Karolina ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Chronic disease; Comorbidities; Geriatrics; Internal medicine; The elderly

Indexed keywords

AGING; ANEMIA; ATHEROSCLEROSIS; CACHEXIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMORBIDITY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DYSLIPIDEMIA; GERIATRIC DISORDER; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FAILURE; LUNG DISEASE; METABOLIC DISORDER; MOTOR NEURON DISEASE; PATHOGENESIS; REVIEW;

EID: 67249127531     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.668     Document Type: Review

References (44)

1. Fabbri LM, Ferrari L. Chronic disease in the elderly: back to the future of internal medicine. Breathe. 2006; 3:41-49.
2. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005:29: 716-724.
3. Gajewski P, Jaeschke R, Brozek J, Schünemann H. Can clinical practice guidelines lead astray? Pol Arch MedWewn. 2007; 117:132-135.
4. de Groot V, Beckerman H, Langhorst GJ, et al. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003; 56: 221-229.
5. Falk JA, Kadiev S, Criner GJ, et al. Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008; 5: 543-548.
6. Mannino DM, Watt G, Hole D, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J. 2006; 27:627-643.
7. Van Weel C, Schellevis FG. Comorbidity and guidelines: conflicting interests. Lancet. 200$; 367; 550-551.
8. Agusti A, Soriano JB. C0PD as a systemic disease. COPD. 2008; 5: 133-138.
9. Rennard S. Inflammation in COPD: a link to systemic comorbidities. Eur Respir Rev. 2007; 16: 91-97.
10. Foschino Barbara MP, Carpagnano GE, Spanevello A, et al. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease. Int J Immunopathol Pharmacol. 2007; 20:753-763.
11. Van Helvoort HA, Heijdra YF, Thijs HM, et al. Exercise-induced systemic effects in musclewasted patients with COPD. Med Sci Sports Ex-erc. 2006; 38:1543-1552.
12. Wislowska M, Jaszczyk B, Kochmański M, et al. Diastolic heart function in RA patients. Rheumatol Int. 2008; 28: 513-519.
13. Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: role of comorbidities. Eur Respir J. 2006; 28:1245-1257.
14. Woloshin S, Schwartz LM, Welch HG. The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J Natl Cancer Inst. 2008; 100: 845-853.
15. Sharma M, Rai SK, Tiwari RK, et al. Effects of nitric oxide modulators on cardiovascular risk factors in mild hyperhomocysteinaemic rat model. Basic Clin Pharmacol Toxicol. 2008; 103: 25-30.
16. Montagnana M, Lippi G, Salvagno GL, et al. Role of biochemical risk factor and markers in the atherosclerosis process. Recenti Prog Med. 2008; 99:215-222.
17. Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA. 2006; 295: 547-553.
18. Hahn BH, McMahon M. Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies. Lupus. 2008; 17: 368-370.
19. Jawień J. New insights into immunological aspects of atherosclerosis. Pol Arch Med Wewn. 2008; 118:127-131.
20. Brandt NJ, Lin M, Patel P. Weight loss in the elderly: medications complicating the picture? Consult Pharm. 2005; 20:976-979.
21. Tarmonova Liu, Shutov AM, Chemysheva EV. Factors influencing left ventricular diastolic function in elderiy patients with chronic heart failure. Klin Med (Mosk). 2007; 85: 26-29.
22. Caughey GE, Vitry Al, Gilbert AL, et al. Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health. 2008; 8:221.
23. Frost RJ, Sonne C, Wehr U, et al. Effects of calcium supplementation on bone loss and fractures in congestive heart failure. Eur J Endocrinol. 2007; 156: 309-314.
24. lonescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J. 2003; 22:64-75.
25. Mundy GR. Osteoporosis and inflammation. Nutr Rev. 2007; 65: S147-S151.
26. Khosla S, Amin S, Orwoll E. Osteoporosis in men. Endocr Rev. 2008; 29:441-464.
27. Brown SA, Clines GA, Guise TA. Local effects of malignancy on bone. Curr Opin Endocrinol Diabetes Obes. 2007; 14: 436-441.
28. Lainscak M, Filippatos GS, Gheorghiade M, et al. Cachexia: common, deadly, with an urgent need for precise definition and new therapies. Am J Cardiol. 2008; 101:8E-10E.
29. Aniwidyaningsih W, Varraso R, Cano N, et al. Impact of nutritional status on body functioning in chronic obstructive pulmonary disease and how to intervene. Curr Opin Clin Nutr Metab Care. 2008; 11:435-442.
30. Murphy CL, McMurray JJ. Approaches to the treatment of anaemia in patients with chronic heart failure. Heart Fail Rev. 2008; 13:431-438.
31. Eisenstaedt R, Pennix BWJH, Woodman R. Anemia in the elderly: Current understanding and emerging concepts. Blood Rev. 2D06; 20: 213-226.
32. Penninx BW, Pahor M, Cesari M, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004; 52: 719-724.
33. Andrews MC. Anemia of inflammation-the cytokine-hepcidin link. J Clin Invest. 2004; 113:1251-1253.
34. Argento V, Roylance J, Skudlarska B, et al. Anemia prevalence in a home visit geriatric population. J Am Med Dir Assoc. 2008; 9: 422-426.
35. Kerem M, Ferahkose Z, Yilmaz UT, et al. Adipokines and ghrelin in gastric cancer cachexia. World J Gastroenterol. 2008; 14:3633-3641.
36. Kailio P Kolehmainen M, Laaksonen DE, et al. Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individuals with the metabolic syndrome. Am J Clin Nutr. 2008; 87:1497-1503.
37. Movahed MR, Milne N. Presence of biventricular dysfunction in patients with type II diabetes mellitus. Congest Heart Fail. 2007; 13:78-80.
38. Alia F, Kearney-Schwartz A, Radauceanu A, et al. Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes. Eur J Heart Fail. 2006; 8: 147-153.
39. Chatila WM, Thomashow BM, Minai OA, et al. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008; 5: 549-555.
40. Prakash J, Hota JK, Singh S, et al. Clinical spectrum of chronic renal failure in the elderly: a hospital based study from eastern India. Int Urol Nephrol. 2006; 38:821-827.
41. Halpin D. Mortality in C0PD: inevitable or preventable? Insights from the cardiovascular arena. COPD. 2008; 5:187-200.
42. Martinez-Hervas S, Romero P, Hevilla EB, et al. Classical cardiovascular risk factors according to fasting plasma glucose levels. Eur J Intern Med. 2008; 19: 209-213.
43. Agustsson T, Rydén M, Hoffstedt J, et al. Mechanism of increased li-polysis in cancer cachexia. Cancer Res. 2007; 67:5531-5537.
44. Kalantar-Zadeh K, Anker SD, Horwich TB, et al. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol. 2008; 101: E89-E103.